PaxVax picked up the FDA’s “fast track” tag for its Chikungunya vaccine. More: FDA places PaxVax's phase 2 Chikungunya shot on its 'fast track' Source: fierce
read moreJohnson & Johnson’s Darzalex just vaulted ahead of its myeloma competitors—and it has plenty of them. Monday, the FDA greenlighted the drug—in combination with Takeda’s Velcade and prednisone—in first-line multiple myeloma patients who are transplant ineligible, making it the first
read moreAstraZeneca is back at it again with its asset sales. The company offloaded certain Seroquel rights to Luye Pharma for up to $538 million. More: AstraZeneca continues yard-sale strategy with 8M Seroquel rights deal Source: fierce
read moreSouth Africa’s Aspen Pharmacare is expanding into complex drugs for cancer and other conditions and has just opened an $80 million facility that can produce them, adding about 500 jobs in the process. More: South Africa's Aspen opens M high
read moreShire and Takeda have finally, officially, agreed on a deal. The Japanese drugmaker will shell out $62 billion on the rare disease specialist, almost half of that in cash. Now, it’ll be up to Takeda to make the buyout pay,
read moreAstraZeneca has sold off certain rights to its antipsychotics Seroquel and Seroquel XR in certain territories – including the UK – to Luye Pharma. More: AstraZeneca sheds Seroquel rights Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals